购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • iGluR
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 35日内发货
    (1)
筛选
搜索结果
TargetMol产品目录中 "

orlistat d3

"的结果
  • 抑制剂&激动剂
    2
    TargetMol | Inhibitors_Agonists
  • 同位素
    1
    TargetMol | Isotope_Products
  • TAK-137
    TAK137
    T708801358749-55-9In house
    TAK-137 是一种 AMPA 受体增强剂,具有抗抑郁作用。TAK-137 具有改善认知的能力,可用于研究神经分裂症。
    • ¥ 1980
    In stock
    规格
    数量
    TargetMol | Inhibitor Hot
  • Orlistat-d3
    T708821356930-46-5
    Orlistat-d3 is intended for use as an internal standard for the quantification of orlistat by GC- or LC-MS. Orlistat is a digestive lipase inhibitor. It inhibits diacylglycerol lipase α (DAGLα), DAGLβ, α β-hydrolase domain-containing protein 12 (ABHD12), ABHD16A, and platelet-activating factor acetylhydrolase (PAF-AH; IC50s = 0.06, 0.1, 0.08, 0.03, and 0.05 µM, respectively), as well as pancreatic lipase and hormone-sensitive lipase (IC50s = 0.65 and 2.1 µg ml, respectively) but does not inhibit fatty acid amide hydrolase (FAAH) or KIAA1363 (IC50s = >100 µM for both). Orlistat decreases ionomycin-induced production of the endocannabinoid 2-arachidonoyl glycerol (2-AG) in N18TG2 murine neuroblastoma cells when used at a concentration of 1 µM. It also inhibits fatty acid synthase (FASN; Kiapp = ~0.1 µM for the human enzyme) and the proliferation of PC3 prostate cancer cells in a concentration-dependent manner. Orlistat (10 mg kg) decreases serum cholesterol levels and total bod......
    • 待估
    35日内发货
    规格
    数量